The role of neoadjuvant therapy in pancreatic cancer: a review.

Item

http://www.wikidata.org/entity/Q38734981

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The role of neoadjuvant therapy in pancreatic cancer: a review.

@en

type

Item

label

The role of neoadjuvant therapy in pancreatic cancer: a review.

@en

prefLabel

The role of neoadjuvant therapy in pancreatic cancer: a review.

@en

P1476

The role of neoadjuvant therapy in pancreatic cancer: a review.

@en

P2093

Jennifer Dorth

http://www.w3.org/2001/XMLSchema#string

Jennifer Eads

http://www.w3.org/2001/XMLSchema#string

John Ammori

http://www.w3.org/2001/XMLSchema#string

Suzanne Russo

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin.

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancer

P304

669-685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.2217/FON.15.335

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26880384

http://www.w3.org/2001/XMLSchema#string

P932

5549642

http://www.w3.org/2001/XMLSchema#string